Patterns of relapse after definitive chemoradiotherapy in stage II/III (non-T4) esophageal squamous cell carcinoma
Oncology Nov 01, 2017
Sudo K, et al. - This study assessed the utility of surveillance after definitive chemoradiotherapy (dCRT) in patients with squamous cell carcinoma. After dCRT, surveillance with esophagogastroduodenoscopy us crucial to detect luminal relapse in the first 3 years and to detect new cancer diagnosed by esophagogastroduodenoscopy beyond 3 years.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
